STING1 and neoplasm: As an emerging class of immunotherapeutic agents, oncolytic viruses (OV) induce ICD, promoting the release of DAMPs and activating innate immune pathways such as cGAS-STING, thereby transforming “cold” tumors into “hot” phenotypes and eliciting robust anti-tumor responses.